Liesbeth Spruijt
- Molecular Biology top 10%
- Genetics top 5%
- Cancer Research top 10%
- Clinical Biochemistry top 2%
- Oncology
- Co-authors
- I.F.M. de CooArjen R. MensenkampHan G. BrunnerHeleen H. ArtsRonald RoepmanDorus A. MansNicoline HoogerbruggeNine V.A.M. Knoers
- Topics
- Mitochondrial Function and Pathology (9 papers)Metabolism and Genetic Disorders (7 papers)BRCA gene mutations in cancer (6 papers)
- Journals
- Journal of Clinical OncologyGastroenterologyThe Journal of Clinical Endocrinology & Metabolism
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Liesbeth Spruijt
42 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 90
- Molecular Biology 1.0k
- Genetics 620
- Cancer Research 222
- Clinical Biochemistry 214
- Oncology 195
Countries citing papers authored by Liesbeth Spruijt
This map shows the geographic impact of Liesbeth Spruijt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liesbeth Spruijt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liesbeth Spruijt more than expected).
Fields of papers citing papers by Liesbeth Spruijt
This network shows the impact of papers produced by Liesbeth Spruijt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liesbeth Spruijt. The network helps show where Liesbeth Spruijt may publish in the future.
Co-authorship network of co-authors of Liesbeth Spruijt
This figure shows the co-authorship network connecting the top 25 collaborators of Liesbeth Spruijt. A scholar is included among the top collaborators of Liesbeth Spruijt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liesbeth Spruijt. Liesbeth Spruijt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 56 | |
| 3 | 35 | |
| 4 | 17 | |
| 5 | 3 | |
| 6 | 11 | |
| 7 | 1 | |
| 8 | 102 | |
| 9 | 197 | |
| 10 | 19 | |
| 11 | 41 | |
| 12 | 49 | |
| 13 | 9 | |
| 14 | 11 | |
| 15 | 144 | |
| 16 | 65 | |
| 17 | 7 | |
| 18 | 91 | |
| 19 | 61 | |
| 20 | 47 |
About Liesbeth Spruijt
Liesbeth Spruijt is a scholar working on Clinical Biochemistry, Genetics and Molecular Biology, having authored 43 papers that have together received 1.6k indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (9 papers), Metabolism and Genetic Disorders (7 papers) and BRCA gene mutations in cancer (6 papers). The work is most often cited by research in Clinical Biochemistry (214 citations), Genetics (620 citations) and Molecular Biology (1.0k citations). Liesbeth Spruijt has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include I.F.M. de Coo, Arjen R. Mensenkamp, Han G. Brunner, Heleen H. Arts, Ronald Roepman, Dorus A. Mans, Nicoline Hoogerbrugge, Nine V.A.M. Knoers, Christian Gilissen and Christine de Die‐Smulders. Their work appears in journals such as Journal of Clinical Oncology, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.